Multipotent mesenchymal stem cells with extensive self-renewal properties can be easily isolated and rapidly expanded in culture from small volumes of amniotic fluid. These cells, namely amniotic fluid-stromal cells (AFSC), can be regarded as an attractive source
for tissue engineering purposes, being phenotipically and genetically stable, plus overcoming all the safety and ethical issues related to the use of embryonic/fetal cells. LMP3 is a novel osteo-inductive molecule acting upstream to the main osteogenic
pathways. This study is aimed at delineating the basic molecular events underlying LMP3-induced osteogenesis, using AFSCs as a cellular model to focus on the molecular features underlying the multipotency/differentiation switch. For this purpose, AFSCs were isolated and characterized in vitro, and transfected with a defective adenoviral
vector expressing the human LMP3. LMP3 induced the successful osteogenic
differentiation of AFSC by inducing the expression of osteogenic markers and osteospecific transciption factors. Moreover, LMP3 induced an early repression of the kruppellike
factors-4, implicated in MSC stemness maintenance. KLF4 repression was released upon LMP3 silencing, indicating that this events could be reasonably considered among
the basic molecular events that govern the proliferation/differentiation switch during LMP3-induced osteogenic differentiation of AFSC.
- amniotic fluid stromal cells